title: [Guidelines of the Pharmaceutical Benefits Board for health economics evaluations. Cost-efficiency analysis from a national perspective].
authors.affiliation: Linköpings universitet.
authors.forename: Douglas
authors.initials: D
authors.lastname: Lundin
authors.forename: Per
authors.initials: P
authors.lastname: Carlsson
authors.forename: Lars-Ake
authors.initials: LA
authors.lastname: Levin
authors.forename: Ulf
authors.initials: U
authors.lastname: Persson
mesh_terms: D003362:Cost-Benefit Analysis; D016527:Drug Costs; D004470:Economics, Medical; D017408:Guidelines as Topic; D007348:Insurance, Health / Q000191:economics; D019057:Quality-Adjusted Life Years; D013548:Sweden